In the year 2002, 2,500 women will have been diagnosed with ovarian cancer. Treatment for ovarian cancer is arduous, involving invasive surgery, chemotherapy, and/or radiation therapy. Studies have described the side effects of ovarian cancer treatment, but little has been written about women's perspectives on receiving that treatment.
Background information
Ovarian cancer is described as having four disease stages (Thompson, Szukiewicz-Nugent, & Walczak, 1996) . In stage I, when the cancer is limited to the ovaries, surgical treatment is often deemed sufficient and adjuvant treatment may not be required. However, all other stages of the disease are treated with a combination of surgery, chemotherapy, and radiation. Stage II disease involves one or both ovaries and extends into the pelvic cavity. Stage III disease is present in one or both ovaries, peritoneal implants outside the pelvis, malignant cells in retroperitoneal or inguinal lymph nodes, or superficial liver metastasis. Stage IV disease involves one or both ovaries with distant metastases including positive pleural effusion or liver involvement. Seventy-five per cent of women are diagnosed with Stage III or IV disease.
Treatment for ovarian cancer usually includes surgery, chemotherapy, and/or radiotherapy. A total abdominal hysterectomy, bilateral salpingo-oophorectomy with omentectomy, and debulking of the tumour are done initially to stage the tumour, confirm diagnosis, and remove as much tumour as possible. Radiation treatments and various combinations of chemotherapy agents are given in an attempt to diminish symptoms, ward off a recurrence, and improve survival rates. To date, hormone treatment and immunotherapy offer little benefit over standard chemotherapy regimes. A combination platinum chemotherapy consisting of cisplatin and carboplatin and/or Taxol® is the first line chemotherapy of choice in Canada. Although the standard treatment for chemotherapy, platinum-based chemotherapy, provides a 70-80% response rate, long-term survival rates remain poor (Balat et al., 1996) .
Chemotherapy, together with surgery and radiation, has side effects and the potential to impact upon the woman (Kornblith et al., 1995; Portenoy et al., 1994) . The chemotherapy regimen, considered the 'big guns', is often physically overwhelming for women. Side effects from chemotherapy relate to the type of agent used. Cisplatin is associated with moderate to severe nausea, hearing loss, and peripheral neuropathy. Carboplatin is generally better tolerated, but is limited by toxicity levels of thrombocytopenia (Miller, 1999) . Although studies have described the incidence and prevalence of side effects (Portenoy et al.) , little attention has been paid to describing women's perspectives about undergoing treatment for ovarian cancer (Schaefer, Ladd, Lammers, & Echenberg, 1999) . A better understanding of women's experiences could help to provide insight regarding beneficial interventions.
Purpose of the study
The purpose of the study was to describe the experiences of women who had been diagnosed with ovarian cancer. This qualitative work explored the perspectives of women living with ovarian cancer. It was anticipated that by understanding their viewpoints regarding their experiences during diagnosis, treatment, and follow-up care, insight could be gained to help improve the delivery of care, as well as provide ideas for future research. The purpose of this paper is to describe a portion of the findings -women's experiences during treatment.
Method
The study sample consisted of 18 women who were invited to share their experiences regarding treatment for ovarian cancer. Women were identified in two ways: 1) by asking nurses and gynecologic oncologists in two major cancer centres to invite women diagnosed with ovarian cancer to participate in the interview, and 2) by a local ovarian cancer support group extending the same invitation to be interviewed. The criteria for participation included: 1) ovarian cancer diagnosis, 2) able to speak English, and 3) able to talk about their experiences. Potential participants were asked to give permission for the nurse researcher to receive their names and telephone numbers. The research nurse called interested women to explain the purpose of the study and to schedule an interview at a time convenient to them. Information about participation not affecting their care, ethical issues including confidentiality, and the reporting of aggregated data was given before a verbal consent was obtained from each woman. The study was approved by the ethics committee of Sunnybrook & Women's College Health Sciences Centre.
Interviews, lasting approximately one hour, were conducted over the telephone and audiotaped. They were conducted by a Mastersprepared nurse with expertise in qualitative data collection, and were guided by a semi-structured interview schedule. The interview schedule was designed for this study. It served as a stimulus to help women describe their experiences, and included open-ended questions related to women's experiences with diagnosis and treatment, making therapy choices, obtaining information, involvement in decisions, impact of illness, changes in lifestyle, and obtaining supportive care. The participants were asked at the start of the interview to talk about what had happened to them with regards to their ovarian cancer from the time they were first aware something was different about their bodies to the time of the interview. The interviewer listened as the woman shared her experiences and probed with the interview questions only if the woman did not volunteer the information. Demographic information (i.e., age, marital status, length of time since diagnosis, number of children, education, and current work status) was gathered to provide a description of the participants.
Interview data were transcribed verbatim and all 18 transcripts were read by the three authors independently (MF, KD, DH). Subsequently, working together and comparing impressions of each woman's story, the three authors designed a broad coding scheme for the data. This scheme facilitated the organization of the data into broad content categories according to the trajectory of illness experiences (i.e., peridiagnosis, diagnostic, treatment, rehabilitation, recurrence, etc.) . Data were then coded by one author (KD) according to the categories developed by the three authors (MF, KD, DH). The overall scheme did not change during the course of the coding. Each category was then reviewed by the team and theme labels were generated to reflect the broad ideas women shared.
During the analysis, it became apparent that there was a wealth of information contained in the interviews. To do justice to the data, the team decided to write several articles from these findings. This article will focus on the perspectives women shared about the treatment period. Other articles by the authors will discuss the findings from this qualitative study concerning women's experiences during the peridiagnostic period, impact of the disease on the family, and dealing with recurrence.
Findings
Three themes related to women's experiences with treatment for ovarian cancer and dealing with side effects are described in this article. Pseudonyms are used in the text.
Sample
Eighteen women were interviewed about their experience with ovarian cancer. The mean age for the women was 53.2 years (range of 35-73). More than half of the women (n=12) had been diagnosed in the 12 months prior to being interviewed. The mode for the time since diagnosis was five months. Five women were longer-term survivors, having lived between 13 months and 12 years since diagnosis.
Twelve women in the sample were married and six were without a partner, being either single, separated, divorced, or widowed. Six women did not have any children while 12 had between one and four. Two women completed primary school education, six completed secondary school, seven attended university, and three attained college diplomas. Eight women did not work outside the home by choice or because of retirement. Six women were on long-term disability from their jobs. Four women had returned to work on a parttime or full-time basis after their diagnosis and initial treatment.
Theme one: Initial treatment plans were overwhelming
Women were stunned by the initial diagnosis of ovarian cancer and the treatment requirements for their disease. Although many had been experiencing symptoms such as bloating, fatigue, gastrointestinal symptoms, and pain, most had not considered ovarian cancer a possible cause of the symptoms. Hearing the diagnosis evoked shock and feelings of fear.
...And the doctor came to me and he told me that there was cancer all over all the insides...So that was rather shocking. [Maria] This was, sort of, like completely out of the blue. It was diagnosed as primary ovarian cancer. I went bananas...It was to me the kiss of death. That was, our, very first reaction.
[Ellen]
So then he (gynecologist) phoned me at home...I had to have surgery right away. And he said it would be in about a week. "Get your affairs in order, drop out of university. You're going to be off for six weeks at least after the surgery"...and it also terrified me, you know, that I was going to be off for six weeks -giving me the impression that I was going to be in terrible pain.
[Gail]
The majority of the women in this study were quite ill at the time of diagnosis, having endured arduous investigations prior to receiving a definitive diagnosis. Surgical treatment was often needed on an urgent basis. Decisions about this initial treatment were made quickly for the women, leaving many feeling as though they "were on an assembly line" and being rushed through treatment.
He The severity of the disease and the urgency for treating it sometimes posed particular problems for younger women. Not only were there issues regarding child care to resolve, but personal goals such as having a child were interrupted by the urgency of the treatment need.
At that time (diagnosis) I wanted to have more children...finally my doctor said "it's time, we can't wait any longer...you're not pregnant yet so...we have to do the hysterectomy"...I had a hysterectomy and oophorectomy and also there was some bowel. It was a terrible hysterectomy. It was just awful. I had an anxiety attack on the operating table.
[Mary]
The speed with which events unfolded allowed little time for planning. This was particularly an issue for mothers or single parent families.
Theme two: Involvement in treatment decision-making was minimal
Women in this study perceived they had minimal input into initial decision-making about their treatment. The women presented with severe symptoms. They were often very ill at the time of diagnosis and wanted something done to relieve their distress. They perceived that the initial treatment protocols were frequently determined by the surgeon and oncologist and, in large measure, they went along with the physician's recommendations. Few sought a second opinion.
Well Even when women were invited to participate in the treatment decision, they felt they were neither psychologically prepared nor equipped with adequate knowledge to contribute to the decisionmaking process.
We conjunctively [sic] The women in this study also felt little or no involvement in decisions regarding adjuvant treatment because of the complex nature of the treatments as well as their capacity to confront the implications of the treatment. Still trying to come to terms with the diagnosis, the need for additional treatment was overwhelming. Women had to learn new terminology and understand the strategies for treating the cancer before feeling capable of participating in the decision-making process. The various treatment protocols were confusing for the women to sort out during a time of heightened anxiety. Many felt they did not have the necessary information.
And it (diagnosis) was
Certainly nothing written! And very little verbal. In fact, they were telling me I would have the chemo, and I didn't even know what the chemo involved.
Frustration arose when the women did not receive support and understanding about their need to learn from health professionals.
I Many women talked about searching for information on their own or with the help of their family members or friends.
I had to search out a lot of the information on my own. I had to because a lot of, especially when I was first diagnosed, a lot of the answers to my questions were "I don't know" from the medical profession.
The following interpretation of the health care professionals' response to questions was shared by many of the women. The importance of information was described by many of the women. In the words of one individual, "I can't imagine anyone going through this without knowing what the hell's going on!" The women were clear that information could be useful, but that it also could be hurtful.
You In summary, women felt carried along by a tide of events where their input was not integral to the treatment decision. In the words of one woman, "The doctor said, 'Well ultimately, it's up to you; you can always say no', but there wasn't much choice."
Theme three: Treatment had many side effects and complications
Seventeen women in this study underwent surgery consisting of a hysterectomy, bilateral oophorectomy, omentectomy, and sometimes bowel resection resulting in a colostomy. The surgery permitted appropriate staging of the ovarian cancer, allowed doctors to assess pre-surgical chemotherapy effects, and helped to determine if patients would need adjuvant treatment. Seventeen of the women had chemotherapy. These women reported many difficulties with the heavy chemotherapy regimens, including nausea, vomiting, allergies, fatigue, alopecia, physical aches, and emotional burdens. They often experienced more than one side effect and found the whole situation draining. Women learned to tolerate the side effects and take advantage of the times when they felt better between treatments. At these times, the women in the study tried to focus on engaging in pleasurable personal and family activities.
It ( Some women were fortunate to experience few side effects from chemotherapy treatment. What they experienced was managed by medications and resulted in minimal emotional toil.
It (chemotherapy) was a bit frightening but then after that I decided it wasn't as bad as all that. It was just a needle and it was going to make everything right. So after the first one (treatment) I was fine. I didn't have an awful lot of nausea. I had the anti-nausea medication that they give you these days 
Discussion
This paper describes the perspectives of 18 women living with ovarian cancer about the initial treatment interval for their cancer. The findings provide insight into their views of the events surrounding treatment decision-making and their experiences receiving treatment. Two-thirds of those who participated were within one year of their initial diagnosis of cancer and had completed a first course of therapy.
The treatment regimens women with ovarian cancer undergo are arduous, taking a heavy toll both physically and emotionally. In this study, combined therapies were utilized, creating significant demands upon these women. Not only were demands made in terms of dealing with side effects and complications, but demands were also made around travelling for treatment, spending lengthy periods of time in the treatment facility, and not being able to engage in usual household and family responsibilities. The value of effective symptom management is highlighted in this study. When side effects were well managed, women described being able to carry on with daily activities. Those who had to struggle to control side effects found it used up what little energy they had and compromised their capacity to engage in desired activities/interactions. The types of symptoms and side effects these women described are similar to those reported in previous literature. The new insight emerging from this study is the description of the impact effective symptom management has on the women's capacity to cope and to engage in decision-making.
The women described minimal involvement in initial treatment decision-making. Most felt treatment decisions were made by the physician. As patients, they went along with the decision, primarily because they wanted help for the discomfort they were experiencing, or because they felt they did not know enough about either ovarian cancer or its treatment to make a contribution. Most felt caught up in a chain of events over which they had little control.
Additionally, women described little involvement in treatment decision-making following the initial surgical intervention. After recovery from the massive surgical procedure, women felt better, but still experienced difficulty participating in treatment decisionmaking. Similar perspectives regarding being caught in a chain of events and feeling little control have been reported by other cancer patients (Dollinger, Rosenbaum, & Cable, 1997) . In particular, individuals who experience the need for rapid surgical intervention with resultant hospitalization (i.e., bowel obstruction) face the unexpected disruption caused by these events, as well as the implications of a malignant diagnosis. Hospitalization has the potential to disrupt family and work responsibilities. Surgery has the potential to disrupt normal body functions. The cancer diagnosis has the potential to disrupt future dreams, one's sense of mortality, and feelings of security. Adding to the sense of upheaval and uncertainty is a feeling of urgency about treating cancer that is voiced by health care professionals and perceived by the patient. Tension emerged between the urgency to get the treatment plan underway, the need to make appropriate arrangements about family and work responsibilities, and the need to come to terms with the diagnosis itself.
Another issue that may have increased the tension and inability to participate in treatment decision-making for women and their family members was the lack of information about ovarian cancer and cancer treatment. The women in this study described how their own lack of knowledge influenced their ability to be engaged in decision-making about treatment and to cope with the side effects of treatment. Knowledge about the type of information that is most likely to help patients engage in treatment decision-making (i.e., the nature of the disease or medical reasons for initiating particular treatments, the medical procedures to be carried out, the expected side effects, and the strategies patients can use to cope with the upcoming threat) was described many years ago (Cohen & Lazarus, 1979; Derdiarian, 1987) . It is disconcerting to learn that women are still facing difficulties accessing this information from their primary cancer care teams.
The literature has shown that patients with cancer in every age group want maximum amounts of information; however, not all patients want to be involved in the treatment decision-making to the same extent (Davison, Degner, & Morgan, 1995; Hack, Degner, & Dyck, 1994) . Thus, there are likely differences in preferred decisionmaking involvement among the women in a group, but there also may be differences over the course of the treatment. It is of interest to observe how the women in this study seemingly "went along with" the decision made by the physician team. It is important to acknowledge that many of these women were seriously ill at the time of their diagnosis. Some had been experiencing symptoms for a period of time. Accepting a particular course of treatment was seen as the route to symptom relief without further waiting. Many also had limited information about ovarian cancer and its treatment at the beginning of their experience. It is of interest to note this seemingly passive stance around decision-making was not evident at the time of recurrent disease (Howell, Fitch, Deane, & Gray, 2002) . By the time recurrent disease is evident, women reported having a vastly different knowledge about ovarian cancer and had experienced one course of treatment. For many, their participation in decision-making was considered more active than with the initial diagnosis.
The notion that cancer patients prefer their physicians to make a treatment decision has been reported by a number of authors (Davison et al., 1995; Degner & Sloane, 1992; Sutherland, Llewellyn-Thomas, Lockwood, Trichler, & Till, 1989) . In particular, older (Blanchard, LaBreque, Ruckdeschel, & Blanchard, 1988; Cassileth, Zupkis, Sutton-Smith, & March, 1980; Degner & Sloane) , married (Blanchard et al.) , and less educated (Casselith et al.; Degner & Sloane) cancer patients prefer to delegate decision-making responsibility to physicians. However, controversy remains on this issue as other reports describe a desire by patients to participate in decision-making to varying degrees (Brandt, 1991; Degner & Sloan; Degner & Aquino-Russell, 1988; Hack et al., 1994) .
Treatment decision-making occurs within the context of a social situation and, as a result, is influenced by that context, as opposed to being solely the product of the patient's medical condition and available treatment (Degner & Beaton, 1987) . The central factor influencing the way in which treatment decisions are made appears to be "control over the design of treatment" or who actually selects the treatment. Four patterns of decision-making have been described whereby patients play different roles: provider controlled, patient controlled, family controlled, and jointly controlled (Degner & Beaton) . That patients have preferences for the role they take or the control they assume is evident. Work with breast cancer patients revealed that 22% of women wanted to select their own cancer treatment, 44% wanted to select their treatment collaboratively with their physician, and 34% wanted to delegate this responsibility to their physician. Only 42% of the women believed they had achieved their preferred level of control in decision-making (Degner et al., 1997) . Similar work has not yet emerged for women with ovarian cancer.
It should also be noted that several authors have emphasized that the desire for information is quite separate from the degree of willingness to use this information in making choices (Averill, 1973;  doi:10.5737/1181912x131813 CONJ • 13/1/03 RCSIO • 13/1/03 Degner & Beaton, 1987; Dennis, 1987) . Sutherland and colleagues (1989) have noted that the need for information is likely related to the need to enhance psychological autonomy and not necessarily related to the desire to assume responsibility for treatment decisions. In other words, people may want a great deal of information, but may not want to be making choices about their medical care. Both preference for decision-making and desire for information should be assessed clinically if care is to be tailored to the individual patient.
Implications for oncology nurses
Several implications for oncology nurses emerge from this study. Nurses caring for women who have undergone surgical procedures where ovarian cancer was diagnosed must be sensitive to the individual woman's situation. Talking with each woman about the time before the diagnosis, how the diagnosis was made, the timing of the surgery, and her understanding of her disease will provide insight into that woman's experiences and the pressures she may be feeling. Providing an opportunity for her to voice any questions and concerns could facilitate the woman's access to information she considers relevant.
Nurses caring for women who are undergoing radiation therapy or chemotherapy treatment need to engage in astute symptom assessment and management throughout the course of the regimens. Symptoms that should be of primary importance to nurses include nausea and vomiting, pain, and fatigue. Nurses also need to provide the opportunity for women to voice any questions or concerns they might have about the side effects they may be experiencing. Together, the nurse and the patient ought to determine the pattern of the woman's responses to the treatment regimens so that the woman can develop realistic expectations about when she will need to rest and when she can engage in some of her usual activities.
Throughout the illness continuum, the nurse must continually assess the patient's preference for involvement in decision-making. The patient may wish different degrees of involvement, depending upon the situation. For example, she may wish to leave overall treatment decisions to the physician, but wish to be highly involved in arranging appointment times for her chemotherapy.
Finally, nurses can play an important role in generating patient information tools. Given that individuals learn in various ways, several types of education tools may be of benefit (e.g., brochures, books, videos, etc.). Additionally, there would be value in ensuring women diagnosed with ovarian cancer are aware of local cancer support groups.
This study has provided a brief look at the perspectives of women diagnosed with ovarian cancer regarding their experiences with initial treatment for their disease. Issues have been identified regarding their involvement in decision-making, access to information, and need for astute symptom management. Additional research needs to be conducted to determine the magnitude of these issues in a larger sample and, eventually, to develop appropriate and effective interventions.
